文章名稱引用次數(shù)

• Review of current evidence and clinical recommendations on the effects of low- carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force25
• National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk18
• Relationship between LDL-C, estimated true LDL-C, apolipoprotein B- and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide14
• Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis13
• The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study12
• Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial11
• Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis10
• Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span9
• Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf8
• Management of dyslipidemia in adult solid organ transplant recipients8